151 related articles for article (PubMed ID: 27983526)
1. Pri-miR-34b/c rs4938723 polymorphism increased the risk of prostate cancer.
Hashemi M; Danesh H; Bizhani F; Narouie B; Sotoudeh M; Nouralizadeh A; Sharifiaghdas F; Bahari G; Taheri M
Cancer Biomark; 2017; 18(2):155-159. PubMed ID: 27983526
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
3. Pri-miR-34b/c rs4938723 polymorphism is associated with a decreased risk of gastric cancer.
Pan XM; Sun RF; Li ZH; Guo XM; Qin HJ; Gao LB
Genet Test Mol Biomarkers; 2015 Apr; 19(4):198-202. PubMed ID: 25658980
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the pri-miR-34b/c rs4938723 polymorphism and its association with breast cancer risk.
Sanaei S; Hashemi M; Rezaei M; Hashemi SM; Bahari G; Ghavami S
Biomed Rep; 2016 Jul; 5(1):125-129. PubMed ID: 27347415
[TBL] [Abstract][Full Text] [Related]
5. Pri-miR-34b/c rs4938723 polymorphism is associated with the risk of childhood acute lymphoblastic leukemia.
Hashemi M; Bahari G; Naderi M; Sadeghi-Bojd S; Taheri M
Cancer Genet; 2016 Nov; 209(11):493-496. PubMed ID: 27886674
[TBL] [Abstract][Full Text] [Related]
6. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
[TBL] [Abstract][Full Text] [Related]
7. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
8. The genetic association between pri-miR-34b/c polymorphism (rs4938723 T > C) and susceptibility to cancers: evidence from published studies.
Li X; Wang L; Yu J; Xu J; Du J
Tumour Biol; 2014 Dec; 35(12):12525-34. PubMed ID: 25190019
[TBL] [Abstract][Full Text] [Related]
9. pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.
Liu CJ; Ma XW; Zhang XJ; Shen SQ
Int J Mol Epidemiol Genet; 2017; 8(1):1-7. PubMed ID: 28337312
[TBL] [Abstract][Full Text] [Related]
10. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
[TBL] [Abstract][Full Text] [Related]
11. A genetic variant in the promoter region of miR-34b/c is associated with a reduced risk of colorectal cancer.
Gao LB; Li LJ; Pan XM; Li ZH; Liang WB; Bai P; Zhu YH; Zhang L
Biol Chem; 2013 Mar; 394(3):415-20. PubMed ID: 23183747
[TBL] [Abstract][Full Text] [Related]
12. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
[TBL] [Abstract][Full Text] [Related]
13. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism of the pri-miR-34b/c gene is not associated with susceptibility to congenital heart disease in the Han Chinese population.
Liu YM; Wang Y; Peng W; Wu Z; Wang XH; Wang ML; Wang W; Sun J; Zhang ZD; Mo XM
Genet Mol Res; 2013 Aug; 12(3):2937-44. PubMed ID: 24065649
[TBL] [Abstract][Full Text] [Related]
15. Association between Pri-miR-34b/c rs4938723 polymorphism and bladder cancer risk.
Hashemi M; Hasanpour V; Danesh H; Bizhani F; Narouie B
J Biomed Res; 2018 Sep; 33(1):24-9. PubMed ID: 30190447
[TBL] [Abstract][Full Text] [Related]
16. Association between miR-34b/c rs4938723 polymorphism and risk of cancer: An updated meta-analysis of 27 case-control studies.
Hashemi M; Moazeni-Roodi A; Bahari G; Taheri M; Ghavami S
J Cell Biochem; 2019 Mar; 120(3):3306-3314. PubMed ID: 30203457
[TBL] [Abstract][Full Text] [Related]
17. MiR-34b/c rs4938723 Polymorphism Significantly Decreases the Risk of Digestive Tract Cancer: Meta-analysis.
Ji TX; Zhi C; Guo XG; Zhou Q; Wang GQ; Chen B; Ma FF
Asian Pac J Cancer Prev; 2015; 16(14):6099-104. PubMed ID: 26320502
[TBL] [Abstract][Full Text] [Related]
18. Pri-miR-34b/c rs4938723 TC heterozygote is associated with increased cancer risks: evidence from published data.
Yi DH; Wang BG; Zhong XP; Liu H; Liu YF
Tumour Biol; 2014 Dec; 35(12):11967-75. PubMed ID: 25201061
[TBL] [Abstract][Full Text] [Related]
19. Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.
Narouie B; Ziaee SAM; Basiri A; Hashemi M
Gene; 2017 Aug; 626():354-357. PubMed ID: 28578017
[TBL] [Abstract][Full Text] [Related]
20. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
